scispace - formally typeset
Open AccessJournal ArticleDOI

The VHL/HIF Axis in Clear Cell Renal Carcinoma

Chuan Shen, +1 more
- 01 Feb 2013 - 
- Vol. 23, Iss: 1, pp 18-25
TLDR
Deregulation of HIF2α appears to be a driving force in pVHL-defective clear cell renal carcinomas, and genetic and functional studies suggest that HIF1α serves as a tumor suppressor and is a likely target of the 14q deletions that are characteristic of this tumor type.
About
This article is published in Seminars in Cancer Biology.The article was published on 2013-02-01 and is currently open access. It has received 311 citations till now. The article focuses on the topics: HIF1A & Ubiquitin ligase complex.

read more

Citations
More filters
Journal ArticleDOI

Hypoxia-Inducible Factors: Master Regulators of Cancer Progression

TL;DR: The current understanding of the consequences of HIF activity and the translational potential of targeting HIFs for cancer therapy are discussed.
Journal ArticleDOI

Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement

TL;DR: These findings reveal a tumor-suppressive role for specific tRNA-derived fragments and describe a molecular mechanism for their action, which may generalize to other tRNA, ribosomal-RNA, and sno-RNA fragments.
Journal ArticleDOI

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.

TL;DR: Hereditary pheochromocytomas and paragangliomas are powerful models for recognizing cancer driver events, which can be harnessed for diagnostic purposes and for guiding the future development of targeted therapies.
References
More filters
Journal ArticleDOI

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

TL;DR: Progression-free survival was longer and response rates were higher in patients with metastatic renal-cell cancer who received sunitinib than in those receiving interferon alfa.
Journal ArticleDOI

Targeting of HIF-alpha to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

TL;DR: It is shown that the interaction between human pVHL and a specific domain of the HIF-1α subunit is regulated through hydroxylation of a proline residue by an enzyme the authors have termed Hif-α prolyl-hydroxylase (HIF-PH).
Journal ArticleDOI

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

TL;DR: It is indicated that the interaction between HIF-1 and pVHL is iron dependent, and that it is necessary for the oxygen-dependent degradation of HIF α-subunits, which may underlie the angiogenic phenotype of VHL-associated tumours.
Journal ArticleDOI

Sorafenib in advanced clear-cell renal-cell carcinoma.

TL;DR: As compared with placebo, treatment with sorafenib prolongs progression-free survival in patients with advanced clear-cell renal-cell carcinoma in whom previous therapy has failed; however, treatment is associated with increased toxic effects.
Journal ArticleDOI

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

TL;DR: It is found that human pVHL binds to a short HIF-derived peptide when a conserved proline residue at the core of this peptide is hydroxylated, which may play a key role in mammalian oxygen sensing.
Related Papers (5)

Comprehensivemolecular characterization of clear cell renal cell carcinoma

Chad J. Creighton, +291 more
- 28 Aug 2013 -